Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | oxidoreductase | 0.0005 | 0 | 0.5 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0005 | 0 | 0.5 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0005 | 0 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Toxoplasma gondii | pantoate-beta-alanine ligase | 0.0545 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0 | 0.5 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0005 | 0 | 0.5 |
Brugia malayi | acetyl-Coenzyme A synthetase 2 | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0005 | 0 | 0.5 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0005 | 0 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Trypanosoma brucei | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Echinococcus granulosus | acetyl coenzyme A synthetase cytoplasmic | 0.0005 | 0 | 0.5 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Plasmodium falciparum | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Leishmania major | long-chain-fatty-acid-CoA ligase, putative | 0.0005 | 0 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0005 | 0 | 0.5 |
Mycobacterium ulcerans | bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ACP synthetase | 0.0411 | 0.752 | 0.752 |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Schistosoma mansoni | acetyl-CoA synthetase | 0.0005 | 0 | 0.5 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Plasmodium vivax | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0 | 0.5 |
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 0.0411 | 0.752 | 0.752 |
Echinococcus multilocularis | acetyl coenzyme A synthetase, cytoplasmic | 0.0005 | 0 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0005 | 0 | 0.5 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0005 | 0 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Mycobacterium ulcerans | pantoate--beta-alanine ligase | 0.0545 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0 | 0.5 |
Entamoeba histolytica | long-chain-fatty-acid--CoA ligase, putative | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0 | 0.5 |
Mycobacterium tuberculosis | Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) | 0.0545 | 1 | 1 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0 | 0.5 |
Trypanosoma brucei | long-chain-fatty-acid-CoA ligase, putative | 0.0005 | 0 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0005 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.